<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0032">
 <label>32.</label>
 <mixed-citation publication-type="journal">
  <string-name>
   <surname>Adams</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Goldstein</surname>
   <given-names>LJ</given-names>
  </string-name>, 
  <string-name>
   <surname>Sparano</surname>
   <given-names>JA</given-names>
  </string-name>, et al. 
  <article-title>Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)</article-title>. 
  <source>
   <italic toggle="yes">Oncoimmunology</italic>
  </source>. 
  <year>2015</year>;
  <volume>4</volume>(
  <issue>9</issue>):
  <fpage>e985930</fpage>. doi:
  <pub-id pub-id-type="doi">10.4161/2162402X.2014.985930</pub-id>
  <pub-id pub-id-type="pmid">26405612</pub-id>
 </mixed-citation>
</ref>
